2020
DOI: 10.1016/j.talanta.2020.121171
|View full text |Cite
|
Sign up to set email alerts
|

High sensitive ratiometric fluorescence analysis of trypsin and dithiothreitol based on WS2 QDs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(8 citation statements)
references
References 32 publications
0
8
0
Order By: Relevance
“…Figure 5b plots the R with the trypsin concentration, and the results agree on a linear relation with the trypsin concentration, and the fitting curve is Y = −0.42•logC-1.46 (R 2 = 0.99). The lowest detectable concentration of trypsin arrives at 0.1 pM, which is higher than many reported sensors [8,28,29].…”
Section: Determination Of Trypsin In Serummentioning
confidence: 57%
“…Figure 5b plots the R with the trypsin concentration, and the results agree on a linear relation with the trypsin concentration, and the fitting curve is Y = −0.42•logC-1.46 (R 2 = 0.99). The lowest detectable concentration of trypsin arrives at 0.1 pM, which is higher than many reported sensors [8,28,29].…”
Section: Determination Of Trypsin In Serummentioning
confidence: 57%
“…Based on the Cy5s-Ab-Flu-Aza fluorescence intensity profiles, the ratiometric curve was obtained as the ratio between the green and red signals (Figure , right axis). The half-life (τ 1/2 ) of drug release obtained from both intensity-based and ratiometric profiles, fitted by a second-order exponential function, is about the same, in the order of τ 1/2 ∼ 4.0 ± 0.5 h. Compared to the brightness profiles, the ratiometric curve can be utilized to calculate the drug release degree independently of the sample and instrumental setup. …”
Section: Resultsmentioning
confidence: 95%
“…Targeted drug delivery (TDD) systems, consisting of a drug or prodrug bound to a target-specific carrier such as an antibody, peptide, nanoparticle, or extracellular matrix compounds, facilitate drug delivery, minimize side effects to normal cells and organs, and thereby help to improve the safety of treatment in clinics. , TDD systems additionally equipped with a switchable fluorescent dye (SD) bound to the drug or prodrug through a cleavable linker (Figure a) provide real-time monitoring of drug distribution and accumulation, as well as detection and diagnosis of abnormal cells. , Upon the environment-mediated cleavage of the linker, the switchable dye becomes fluorescent or changes its emission wavelength, signaling the drug release. The fluorescence signal from the dye is, however, affected by the light absorption and scattering in the biological sample, in particular, in the body, and is also dependent on the instrumental setup. , The dual-signal ratiometric fluorescence measurements utilizing a second, nonswitchable reference dye (RD, Figure b) provide internal calibration which eliminates these undesirable factors and improves the detection sensitivity and quantification. …”
Section: Introductionmentioning
confidence: 99%
“…Recently, many efforts have been reported regarding trypsin determination. Several biosensors based on fluorescent, electrochemical, and colorimetric methods have been developed to detect trypsin [15,26,60,61]. Fluorescence-based homogeneous assays are the most popular ones for trypsin activity monitoring due to their simple processes, high sensitivity, and convenient operation.…”
Section: Sprectophtometric Assay Of Protease Activitymentioning
confidence: 99%